Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATEC Alphatec	$10.94 +0.5%	$11.80	$4.88 ▼ $13.14	$1.59B	1.1	2.06 million shs	2.08 million shs
ATRI Atrion	$459.92	$459.06	$274.98 ▼ $503.24	$809.46M	0.69	23,283 shs	N/A
ATRS Antares Pharma	$5.59	$5.59	$3.11 ▼ $5.60	$955.06M	1.15	3.29 million shs	6 shs
KIDS OrthoPediatrics	$20.29 +0.7%	$21.35	$19.52 ▼ $35.99	$489.38M	1.08	200,200 shs	138,889 shs

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATEC Alphatec	0.00%	-4.22%	-16.04%	+9.67%	+4.91%
ATRI Atrion	0.00%	0.00%	0.00%	0.00%	+0.82%
ATRS Antares Pharma	0.00%	0.00%	0.00%	0.00%	0.00%
KIDS OrthoPediatrics	0.00%	-7.23%	-11.97%	-19.30%	-32.70%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATEC Alphatec	4.4169 of 5 stars	3.4	3.0	0.0	3.3	2.6	4.2	0.6
ATRI Atrion	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ATRS Antares Pharma	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	3.7805 of 5 stars	3.4	2.0	0.0	3.9	0.0	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATEC Alphatec	2.89	Moderate Buy	$17.89	63.52% Upside
ATRI Atrion	0.00	N/A	N/A	N/A
ATRS Antares Pharma	0.00	N/A	N/A	N/A
KIDS OrthoPediatrics	2.83	Moderate Buy	$35.83	76.61% Upside

Current Analyst Ratings Breakdown

Latest KIDS, ATRI, ATEC, and ATRS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/16/2025	ATEC Alphatec	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Buy	$18.00
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
5/2/2025	ATEC Alphatec	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$13.00 ➝ $15.00
5/2/2025	ATEC Alphatec	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$16.00 ➝ $16.00
4/14/2025	ATEC Alphatec	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$20.00 ➝ $20.00
4/11/2025	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$26.00 ➝ $24.00
4/9/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/7/2025	KIDS OrthoPediatrics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00

(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATEC Alphatec	$611.56M	2.61	N/A	N/A	($0.10) per share	-109.40
ATRI Atrion	$181.60M	4.46	$19.68 per share	23.37	$138.02 per share	3.33
ATRS Antares Pharma	$183.98M	5.19	$0.13 per share	43.89	$1.03 per share	5.43
KIDS OrthoPediatrics	$204.73M	2.41	N/A	N/A	$14.64 per share	1.39

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATEC Alphatec	-$162.12M	-$1.15	N/A	N/A	N/A	-25.77%	-1,657.19%	-21.53%	7/30/2025 (Estimated)
ATRI Atrion	$19.41M	$10.64	43.23	∞	N/A	10.60%	7.75%	7.12%	N/A
ATRS Antares Pharma	$46.29M	$0.24	23.29	25.41	N/A	21.90%	7.43%	4.92%	N/A
KIDS OrthoPediatrics	-$37.82M	-$1.75	N/A	N/A	N/A	-19.15%	-7.03%	-5.45%	8/4/2025 (Estimated)

Latest KIDS, ATRI, ATEC, and ATRS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million
5/1/2025	Q1 2025	ATEC Alphatec	-$0.12	-$0.35	-$0.23	-$0.35	$167.57 million	$169.18 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATEC Alphatec	N/A	N/A	N/A	N/A	N/A
ATRI Atrion	$8.80	1.91%	N/A	82.71%	21 Years
ATRS Antares Pharma	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATEC Alphatec	N/A	2.75	1.67
ATRI Atrion	N/A	9.18	3.06
ATRS Antares Pharma	0.10	3.08	2.87
KIDS OrthoPediatrics	0.21	6.19	2.99

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATEC Alphatec	66.35%
ATRI Atrion	66.19%
ATRS Antares Pharma	50.41%
KIDS OrthoPediatrics	69.05%

Insider Ownership

Company	Insider Ownership
ATEC Alphatec	20.90%
ATRI Atrion	22.82%
ATRS Antares Pharma	5.90%
KIDS OrthoPediatrics	32.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATEC Alphatec	700	146.17 million	115.62 million	Optionable
ATRI Atrion	720	1.76 million	1.36 million	Not Optionable
ATRS Antares Pharma	201	170.85 million	160.77 million	Optionable
KIDS OrthoPediatrics	200	24.29 million	16.35 million	Optionable

KIDS, ATRI, ATEC, and ATRS Headlines

Recent News About These Companies

Riverbridge Partners LLC Has $9.17 Million Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

June 20 at 6:06 AM | marketbeat.com

Harbor Capital Advisors Inc. Has $3.80 Million Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

June 11, 2025 | marketbeat.com

OrthoPediatrics (NASDAQ:KIDS) Downgraded by Wall Street Zen to "Sell"

June 7, 2025 | marketbeat.com

OrthoPediatrics (NASDAQ:KIDS) Hits New 12-Month Low - Here's Why

June 4, 2025 | marketbeat.com

Bank of America Corp DE Has $1.85 Million Stock Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

June 4, 2025 | marketbeat.com

OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Consensus Rating of "Moderate Buy" from Brokerages

June 2, 2025 | marketbeat.com

OrthoPediatrics Corp. (NASDAQ:KIDS) Shares Purchased by Wellington Management Group LLP

June 1, 2025 | marketbeat.com

422,705 Shares in OrthoPediatrics Corp. (NASDAQ:KIDS) Purchased by Millennium Management LLC

May 26, 2025 | marketbeat.com

AWM Investment Company Inc. Boosts Stock Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

May 23, 2025 | marketbeat.com

Paradigm Capital Management Inc. NY Reduces Stock Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

May 22, 2025 | marketbeat.com

321,405 Shares in OrthoPediatrics Corp. (NASDAQ:KIDS) Bought by Point72 Asset Management L.P.

May 22, 2025 | marketbeat.com

OrthoPediatrics amends acquisition agreement terms

May 15, 2025 | uk.investing.com

GRAMMYÂ® AWARD-WINNING, MULTIPLATINUM GLOBAL SUPERSTAR TYLA TO HOST NICKELODEON KIDS' CHOICE AWARDS 2025--THE BIGGEST PARTY OF THE SUMMER --LIVE ON SATURDAY, JUNE 21, AT 8 P.M. (ET/PT)

May 15, 2025 | prnewswire.com

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting

May 14, 2025 | gurufocus.com

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting

May 14, 2025 | globenewswire.com

OrthoPediatrics Corp. (KIDS) Q1 2025 Earnings Call Transcript

May 11, 2025 | seekingalpha.com

OrthoPediatrics grows 1st quarter revenue

May 9, 2025 | beckersspine.com

Why OrthoPediatrics Corp.’s (KIDS) Stock Is Up 5.61%

May 9, 2025 | aaii.com

OrthoPediatrics Corp (KIDS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

May 8, 2025 | finance.yahoo.com

OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

May 7, 2025 | zacks.com

OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates

May 7, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS, ATRI, ATEC, and ATRS Company Descriptions

Alphatec NASDAQ:ATEC

$10.94 +0.05 (+0.46%)

Closing price 04:00 PM Eastern

Extended Trading

$10.94 +0.01 (+0.05%)

As of 05:45 PM Eastern

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Atrion NASDAQ:ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Antares Pharma NASDAQ:ATRS

Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. It develops, manufactures, and commercializes novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto-injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto-injectors; TLANDO to treat deficiency or absence of endogenous testosterone in adult males; and drug/device products for urologic oncology, immunology, and endocrinology. The company has strategic alliances and partnerships with Pfizer Inc., Idorsia Pharmaceuticals Ltd, Teva Pharmaceutical Industries, Ltd, and AMAG. Antares Pharma, Inc. was incorporated in 1979 and is headquartered in Ewing, New Jersey.

OrthoPediatrics NASDAQ:KIDS

$20.29 +0.14 (+0.69%)

Closing price 04:00 PM Eastern

Extended Trading

$20.28 0.00 (-0.02%)

As of 04:11 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time